JNBA Financial Advisors’s Alaunos Therapeutics TCRT Stock Holding History

JNBA Financial Advisors’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4	Closed	-$1K	–	836
2021 Q4	$1K	Hold	4	–	–	﹤0.01%	804
2021 Q3	$1K	Hold	4	–	–	﹤0.01%	714
2021 Q2	$1K	Hold	4	–	–	﹤0.01%	666
2021 Q1	$2K	Hold	4	–	–	﹤0.01%	612
2020 Q4	$1K	Hold	4	–	–	﹤0.01%	593
2020 Q3	$1K	Hold	4	–	–	﹤0.01%	563
2020 Q2	$2K	Hold	4	–	–	﹤0.01%	524
2020 Q1	$1K	Hold	4	–	–	﹤0.01%	553
2019 Q4	$3K	Hold	4	–	–	﹤0.01%	540
2019 Q3	$2K	Hold	4	–	–	﹤0.01%	556
2019 Q2	$3K	Hold	4	–	–	﹤0.01%	575
2019 Q1	$2K	Hold	4	–	–	﹤0.01%	514
2018 Q4	$1K	Buy	+4	New	+$1.58K	﹤0.01%	512
2018 Q3	–	Sell	-4	Closed	-$2K	–	692
2018 Q2	$2K	Hold	4	–	–	﹤0.01%	495
2018 Q1	$2K	Hold	4	–	–	﹤0.01%	465
2017 Q4	$2K	Hold	4	–	–	﹤0.01%	454
2017 Q3	$3K	Hold	4	–	–	﹤0.01%	428
2017 Q2	$3K	Hold	4	–	–	﹤0.01%	415
2017 Q1	$3K	Hold	4	–	–	﹤0.01%	422
2016 Q4	$3K	Sell	4 -6	-60%	-$5.41K	﹤0.01%	442
2016 Q3	$8K	Buy	10 +6	+150%	+$4.82K	﹤0.01%	1103
2016 Q2	$3K	Hold	4	–	–	﹤0.01%	451
2016 Q1	$4K	Hold	4	–	–	﹤0.01%	443
2015 Q4	$5K	Hold	4	–	–	﹤0.01%	410
2015 Q3	$5K	Hold	4	–	–	﹤0.01%	414
2015 Q2	$7K	Buy	+4	New	+$6.21K	﹤0.01%	383

Other funds holding TCRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

JNBA Financial Advisors's TCRT Position: Q1 2022 in Review

JNBA Financial Advisors sold out of Alaunos Therapeutics (TCRT) in Q1 2022, closing a stake of 4 shares — an estimated $1K sold.

JNBA Financial Advisors first reported a position in TCRT in Q2 2015 and held it in 26 quarters. The position peaked at $8K in Q3 2016. 148 funds tracked by Wall St. Rank hold TCRT as of Q1 2022.

JNBA Financial Advisors reported no remaining Alaunos Therapeutics position as of Q1 2022 after selling out during the quarter.
JNBA Financial Advisors sold 4 Alaunos Therapeutics shares in Q1 2022, an estimated $1K.
JNBA Financial Advisors first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 26 quarters.
JNBA Financial Advisors's Alaunos Therapeutics position peaked at $8K in Q3 2016.
148 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2022.

Based on JNBA Financial Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.